QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: gad.1240504v1 18/20/2479    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dong, J. Articles by Pan, D. Search for Related Content PubMed PubMed Citation Articles by Dong, J. Articles by Pan, D. Social Bookmarking                   What's this?

RESEARCH COMMUNICATION

Tsc2 is not a critical target of Akt during normal Drosophila development

Department of Physiology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390-9040, USA

Signaling by insulin and target of rapamycin are both required for cell growth, but their interrelationships remain poorly defined. It was reported that Akt, an essential component of the insulin pathway, stimulates growth by phosphorylating and inhibiting tuberous sclerosis complex 2 (TSC2). Here we evaluate this model genetically in Drosophila by engineering Tsc2 mutants in which the Akt phosphorylation sites are changed to nonphosphorylatable or phospho-mimicking residues. Strikingly, such mutants completely rescue the lethality and cell growth defects of Tsc2-null mutants. Taken together, our data suggest that Tsc2 is not a critical substrate of Akt in normal Drosophila development.

[Keywords: Cell growth; tumor suppressor; insulin signaling; target of rapamycin (TOR)]

Received July 16, 2004; revised version accepted August 17, 2004.

¹ Corresponding author. E-MAIL duojia.pan{at}utsouthwestern.edu; FAX (214) 648-8885.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				L. Wang, T. E. Harris, R. A. Roth, and J. C. Lawrence Jr PRAS40 Regulates mTORC1 Kinase Activity by Functioning as a Direct Inhibitor of Substrate Binding J. Biol. Chem., July 6, 2007; 282(27): 20036 - 20044. [Abstract] [Full Text] [PDF]

				Y. Tominaga, T. Tamguney, M. Kolesnichenko, B. Bilanges, and D. Stokoe Translational Deregulation in PDK-1-/- Embryonic Stem Cells Mol. Cell. Biol., October 1, 2005; 25(19): 8465 - 8475. [Abstract] [Full Text] [PDF]

				A. Hahn-Windgassen, V. Nogueira, C.-C. Chen, J. E. Skeen, N. Sonenberg, and N. Hay Akt Activates the Mammalian Target of Rapamycin by Regulating Cellular ATP Level and AMPK Activity J. Biol. Chem., September 16, 2005; 280(37): 32081 - 32089. [Abstract] [Full Text] [PDF]

				P. Wlodarski, M. Kasprzycka, X. Liu, M. Marzec, E. S. Robertson, A. Slupianek, and M. A. Wasik Activation of Mammalian Target of Rapamycin in Transformed B Lymphocytes Is Nutrient Dependent but Independent of Akt, Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Kinase, Insulin Growth Factor-I, and Serum Cancer Res., September 1, 2005; 65(17): 7800 - 7808. [Abstract] [Full Text] [PDF]

				D. K. Scheidenhelm, J. Cresswell, C. A. Haipek, T. P. Fleming, R. W. Mercer, and D. H. Gutmann Akt-Dependent Cell Size Regulation by the Adhesion Molecule on Glia Occurs Independently of Phosphatidylinositol 3-Kinase and Rheb Signaling Mol. Cell. Biol., April 15, 2005; 25(8): 3151 - 3162. [Abstract] [Full Text] [PDF]

				M. N. Corradetti, K. Inoki, and K.-L. Guan The Stress-inducted Proteins RTP801 and RTP801L Are Negative Regulators of the Mammalian Target of Rapamycin Pathway J. Biol. Chem., March 18, 2005; 280(11): 9769 - 9772. [Abstract] [Full Text] [PDF]

				K. Inoki, H. Ouyang, Y. Li, and K.-L. Guan Signaling by Target of Rapamycin Proteins in Cell Growth Control Microbiol. Mol. Biol. Rev., March 1, 2005; 69(1): 79 - 100. [Abstract] [Full Text] [PDF]